Abiopharma

Mandatory Warrant Exercise :

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Lim Wee Kian

Financial Statements and Related Announcement: Profit Guidance

General Announcement: Notice to Warrantholders - Expiry of Warrants on 29 June 2026

United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Collective Mining Discovers a New Tungsten Enriched High-Grade Subzone 300 Meters Below Surface at Apollo by Drilling 27.35 m at 37.55 g/t AuEq (1.68% WO3, 11.62 g/t Au, 54 g/t Ag, 0.43% Cu)

HONEYWELL TECHNOLOGIES LAUNCHES AS INDEPENDENT, PURE-PLAY AUTOMATION COMPANY FOLLOWING COMPLETION OF HONEYWELL AEROSPACE SPIN-OFF

Walker & Dunlop Arranges $191 Million Refinance for Office Portfolio Throughout Netherlands